MEN1 and acute myeloid leukemia: The CDK4/6 inhibitors Palbociclib and Abemaciclib have shown synergy with Menin inhibitors in KMT2A‐ und NUP98‐rearranged as well as NPM1‐mutated AML.108, 117, 118